Repare Therapeutics (RPTX) Earnings Date, Estimates & Call Transcripts $0.90 0.00 (0.00%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$0.93 +0.03 (+3.67%) As of 04/11/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Repare Therapeutics Earnings Summary Upcoming Earnings DateMay. 6Before Market OpensEstimatedConsensus EPS (Mar. 3) -$0.77 Actual EPS (Mar. 3) -$0.67 Beat By $0.10 Repare Therapeutics released Q4 2024 earnings on March 3, 2025, reporting an EPS of -$0.67, which topped analysts' consensus estimates of -$0.77 by $0.10. With a trailing EPS of -$2.00, Repare Therapeutics' earnings are expected to decrease next year, from ($2.04) to ($2.96) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)RPTX Upcoming EarningsRepare Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Repare Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Repare Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRPTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RPTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Repare Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.89-$0.89-$0.89 Remove Ads Repare Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------3/3/2025Q4 2024-$0.77-$0.67+$0.10-$0.67$0.67M-11/7/2024--$0.83-$0.81+$0.02-$0.81$5.37M-8/6/2024--$0.85-$0.82+$0.03-$0.82$4.02M$1.07M5/7/2024Q1 2024-$0.10$0.30+$0.40$0.30$34.82M$52.40M2/28/2024Q4 2023-$0.56-$0.67 -$0.11-$0.67$15.92M$13.05M11/9/2023Q3 2023-$0.86-$0.45+$0.41-$0.45$7.03M$2.16M8/9/2023Q2 2023-$0.83-$0.28+$0.55-$0.28$7.28M$30.25M5/9/2023Q1 2023-$0.84-$0.83+$0.01-$0.83$7.05M$5.68M Repare Therapeutics Earnings - Frequently Asked Questions When is Repare Therapeutics's earnings date? Repare Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on RPTX's earnings history. Did Repare Therapeutics beat their earnings estimates last quarter? In the previous quarter, Repare Therapeutics (NASDAQ:RPTX) reported ($0.67) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.77) by $0.10. Learn more on analysts' earnings estimate vs. RPTX's actual earnings. How much revenue does Repare Therapeutics generate each year? Repare Therapeutics (NASDAQ:RPTX) has a recorded annual revenue of $53.48 million. How much profit does Repare Therapeutics generate each year? Repare Therapeutics (NASDAQ:RPTX) has a recorded net income of -$93.80 million. RPTX has generated -$2.00 earnings per share over the last four quarters. What is Repare Therapeutics's EPS forecast for next year? Repare Therapeutics's earnings are expected to decrease from ($2.04) per share to ($2.96) per share in the next year. More Earnings Resources from MarketBeat Related Companies MDWD Earnings RZLT Earnings ACIU Earnings HURA Earnings DBVT Earnings DMAC Earnings CGC Earnings FULC Earnings DERM Earnings ACRS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:RPTX) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RPTX Stock Free RPTX Stock Alerts